A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. (Q43894511)
Jump to navigation
Jump to search
scientific article published in March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. |
scientific article published in March 2004 |
Statements
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy (English)
Adam Garden
Andy Trotti
Paul Symonds
Corey Langer
Rebecca Redman
Thomas F Pajak
Tomas R Fleming
Michael Henke
Jean Bourhis
Elizabeth Junor
Anthony Cmelak
Finbarr Sheehan
Janis Pulliam
Patricia Devitt-Risse
Henry Fuchs
Mark Chambers
Brian O'Sullivan